Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors

Journal of Diabetes and its Complications

Volumn 21, Issue 1, 2007, Pages 20-27

  Ceriello, Antonio ^a   Del Prato, Stefano ^b   Bue Valleskey, Juliana ^c   Beattie, Scott ^c   Gates, Jeffrey ^c   de la Peña, Amparo ^c   Malone, James ^c  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Diabetes; Lispro; NPH; Postprandial; Test meal

Indexed keywords

CHOLESTEROL; FATTY ACID; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN LISPRO; ISOPHANE INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; AREA UNDER THE CURVE; ARTHRALGIA; ARTHRITIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSAGE SCHEDULE COMPARISON; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERLIPIDEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; LIPID ANALYSIS; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STANDARD; TEST MEAL; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CONTINENTAL POPULATION GROUPS; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, ISOPHANE; KINETICS; LIPIDS; LIPOPROTEINS; MIDDLE AGED; POSTPRANDIAL PERIOD; RISK FACTORS;

EID: 33845614094     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2005.11.005     Document Type: Article

References (29)

1. Anderson J.H., Brunelle R.L., Koivisto V.A., Pfutzner A., Trautmann M.E., Vignati L., and DiMarchi R. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group. Diabetes 46 (1997) 265-270
2. Anderson Jr. J.H., Brunelle R.L., Keohane P., Koivisto V.A., Trautmann M.E., Vignati L., and DiMarchi R. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group. Archives of Internal Medicine 157 (1997) 1249-1255
3. Anderson R.A., Evans M.L., Ellis G.R., Graham J., Morris K., Jackson S.K., Lewis M.J., Rees A., and Frenneaux M.P. The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with Type 2 diabetes. Atherosclerosis 154 (2001) 475-483
4. Avignon A., Radauceanu A., and Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in Type 2 diabetes. Diabetes Care 20 12 (1997) 1822-1826
5. Bolli G.B., DiMarchi R.D., Park G.D., Pramming S., and Koivisto V.A. Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia 42 (1999) 1151-1167
6. Ceriello A. The post-prandial state and cardiovascular disease: Relevance to diabetes mellitus. Diabetes Metabolism and Research Reviews 16 (2000) 125-132
7. Ceriello A. The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 46 Suppl. 1 (2003) M9-M16
8. Ceriello A., Quagliaro L., Piconi L., Assaloni R., Da Ros R., Maier A., Esposito K., and Giugliano D. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53 (2004) 701-710
9. Ceriello A., Taboga C., Tonutti L., Quagliaro L., Piconi L., Bais B., Da Ros R., and Motz E. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: Effects of short- and long-term simvastatin treatment. Circulation 106 (2002) 1211-1218
10. Cole T.G., and Parikh N. High-throughput measurement of oxidizability of low-density lipoproteins suitable for use in clinical trials: 1. Clinical Chemistry 45 (1999) 696-699
11. Colwell J.A. Vascular thrombosis in Type II diabetes mellitus. Diabetes 42 (1993) 8-11
12. Coutinho M., Gerstein H.C., Wang Y., and Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22 (1999) 233-240
13. de Vegt F., Dekker J.M., Ruhe H.G., Stehouwer C.D., Nijpels G., Bouter L.M., and Heine R.J. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: The Hoorn Study. Diabetologia 42 (1999) 926-931
14. Endemann D.H., and Schiffrin E.L. Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus. Current Hypertension Reports 6 (2004) 85-89
15. Esposito K., Giugliano D., Nappo F., Marfella R., and for the Campanian Postprandial Hyperglycemia Study Group. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in Type 2 diabetes mellitus. Circulation 110 (2004) 214-219
16. Esposito K., Nicoletti G., and Giugliano D. Obesity, cytokines and endothelial dysfunction: A link for the raised cardiovascular risk associated with visceral obesity. Journal of Endocrinological Investigation 25 (2002) 646-649
17. Gallagher A., and Home P.D. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes. Diabetes Research and Clinical Practice 67 (2005) 196-203
18. Heitzer T., Schlinzig T., Krohn K., Meinertz T., and Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104 (2001) 2673-2678
19. Henry R.R. Preventing cardiovascular complications of Type 2 diabetes: Focus on lipid management. Clinical Diabetes 19 (2001) 113-120
20. Howey D.C., Bowsher R.R., Brunelle R.L., Rowe H.M., Santa P.F., Downing-Shelton J., and Woodworth J.R. [Lys(B28), Pro(B29)]-human insulin: Effect of injection time on postprandial glycemia. Clinical Pharmacology and Therapeutics 58 (1995) 459-469
21. Howey D.C., Bowsher R.R., Brunelle R.L., and Woodworth J.R. [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin. Diabetes 43 (1994) 396-402
22. Jackson C.A., Yudkin J.S., and Forrest R.D. A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey. Diabetes Research and Clinical Practice 17 (1992) 111-123
23. Jagla A., and Schrezenmeir J. Postprandial triglycerides and endothelial function. Experimental and Clinical Endocrinology & Diabetes 109 (2001) S533-S547
24. Lalli C., Ciofetta M., Del Sindaco P., Torlone E., Pampanelli S., Compagnucci P., Cartechini M.G., Bartocci L., Brunetti P., and Bolli G.B. Long-term intensive treatment of Type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Diabetes Care 22 (1999) 468-477
25. Lebovitz H.E. Effect of the postprandial state on nontraditional risk factors. American Journal of Cardiology 88 (2001) 20H-25H
26. Meigs J.B., Nathan D.M., D'Agostino Sr. R.B., and Wilson P.W.F. Fasting and postchallenge glycemia and cardiovascular disease risk: The Framingham Offspring Study. Diabetes Care 25 (2002) 1845-1850
27. Nagelkerke N., Hart A., and Oosting J. The two period binary response cross-over trial. Biometrical Journal 28 (1986) 863-869
28. Schmoelzer I., de Campo A., Pressl H., Stelzl H., Dittrich P., Oettl K., and Wascher T.C. Biphasic insulin aspart compared to biphasic human insulin reduces postprandial hyperlipidemia in patients with Type 2 diabetes. Experimental and Clinical Endocrinology & Diabetes 113 (2005) 176-181
29. Yoshino G., Hirano T., and Kazumi T. Dyslipidemia in diabetes mellitus. Diabetes Research and Clinical Practice 33 (1996) 1-14